Evidence map›Paper›PMID 34643852›Full record

ArticleMagma (New York, N.Y.)2022

Eye-specific quantitative dynamic contrast-enhanced MRI analysis for patients with intraocular masses.

Myriam G Jaarsma-Coes, Teresa A Ferreira, Petra J van Houdt, Uulke A van der Heide, Gregorius P M Luyten, Jan-Willem M Beenakker

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Magma (New York, N.Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Quantitative Perfusion-Weighted Magnetic Resonance Imaging in Uveal Melanoma.Investigative ophthalmology & visual science · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Myriam G Jaarsma-CoesDepartment of Ophthalmology, Leiden University Medical Centre, P.O. 9600, 2300 RC, Leiden, The Netherlands. m.g.jaarsma@lumc.nl.ORCID http://orcid.org/0000-0003-3423-9370
Teresa A FerreiraDepartment of Radiology, Leiden University Medical Centre, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-1115-6292
Petra J van HoudtDepartment of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0001-7431-8386
Uulke A van der HeideDepartment of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-4146-6419
Gregorius P M LuytenDepartment of Ophthalmology, Leiden University Medical Centre, P.O. 9600, 2300 RC, Leiden, The Netherlands.ORCID http://orcid.org/0000-0003-3685-3868
Jan-Willem M BeenakkerDepartment of Ophthalmology, Leiden University Medical Centre, P.O. 9600, 2300 RC, Leiden, The Netherlands.ORCID http://orcid.org/0000-0003-0479-5587

Funding

Stichting voor de Technische Wetenschappen 14654
6 · The paper itself

Abstract

objectiveDynamic contrast enhanced (DCE)-MRI is currently not generally used for intraocular masses as lesions are small, have an inhomogeneous T MATERIALS &

methodsDCE-MRI of 19 uveal melanoma (UM) patients was acquired using a fat-suppressed 3D spoiled gradient echo sequence with TWIST (time-resolved angiography with stochastic trajectories sequence). The analysis consisted of a two-step registration method to correct for both head and eye motion. A T

resultsRegistration significantly improved the concentration curve quality (p < 0.001). The T

conclusionUsing this eye-specific analysis, DCE of intraocular masses is possible which might aid in the diagnosis, prognosis and follow-up of UM.

Indexed as

Contrast MediaMagnetic Resonance ImagingAngiographyHumansMotionPrognosisContrast MediaDynamic contrast enhancedEye diseasesMagnetic resonance imagingPharmacokinetic modellingUveal melanoma

Identifiers

PMID34643852
PMCPMC8995252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.